SBI Securities
OCUL icon

SBI Securities’s Ocular Therapeutix OCUL Stock Holding History

SBI Securities’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.15K Buy
150
+116
+341% +$1.14K ﹤0.01% 2804
2026
Q2 		$334 Sell
34
-1
-3% -$9 ﹤0.01% 3169
2026
Q1 		$296 Buy
35
+4
+13% +$38 ﹤0.01% 3086
2025
Q4 		$376 Sell
31
-9
-23% -$109 ﹤0.01% 2978
2025
Q3 		$468 Sell
40
-16
-29% -$191 ﹤0.01% 2997
2025
Q2 		$520 Hold
56
– – ﹤0.01% 2947
2025
Q1 		$410 Buy
56
+20
+56% +$154 ﹤0.01% 2943
2024
Q4 		$307 Buy
+36
New +$351 ﹤0.01% 3076

Other funds holding OCUL

Deltec Asset Management
Deltec Asset Management New York $642M AUM 16.66% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Courier Capital
Courier Capital Buffalo, New York $2.02B AUM 16.74% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
MGO One Seven
MGO One Seven Beachwood, Ohio $6.08B AUM 21.44% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

SBI Securities's OCUL Position: Q3 2026 in Review

SBI Securities increased its Ocular Therapeutix (OCUL) stake by 341% in Q3 2026, buying an estimated $1.14K and bringing the position to 150 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #2804.

SBI Securities first reported a position in OCUL in Q4 2024 and has held it in 8 quarters since. 47 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.

  • SBI Securities held 150 shares of Ocular Therapeutix worth $1.15K as of Q3 2026.
  • SBI Securities bought 116 Ocular Therapeutix shares in Q3 2026, an estimated $1.14K.
  • Ocular Therapeutix made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2804 holding.
  • SBI Securities first reported a position in Ocular Therapeutix in Q4 2024 and has held it in 8 quarters since.
  • 47 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.